Dr. Andy Southerland talks with Dr. Lidia Moura about the implications of large language models (LLMs) for neurologic care.

Read the related article in Neurology.

Disclosures can be found at Neurology.org.

Dr. Justin Abbatemarco talks with Drs. Michael R. Wilson and John Pluvinage about their discovery of anti-CD320 antibodies in patients with neurologic manifestations of B12 deficiency and discuss the potential implications for diagnosis and treatment.

Read the related article in Science.

Disclosures can be found at Neurology.org.

Dr. Jason Crowell talks with Dr. Campbell Le Heron about the association of clinical and neurocognitive factors with apathy in patients with Parkinson disease.

Read the related article in Neurology.

Disclosures can be found at Neurology.org.

Dr. Justin Abbatemarco talks with Dr. Andrew McKeon about the topic of autoimmune neurology, specifically focusing on the antibody CAMKV and its association with autoimmune encephalitis.

Read the related article in Annals of Neurology.

Disclosures can be found at Neurology.org.

Dr. Jessica Ailani talks with Dr. Ian Carroll about intracranial hypotension, the challenges of diagnosing and treating patients with CSF leaks, and the study's findings.

Read the related article in Neurology.

This podcast is sponsored by argenx. Visit www.vyvgarthcp.com for more information.

Disclosures can be found at Neurology.org.

As part of our "Physician as Patient" series, Dr. Andy Southerland talks with Dr. Eric Seachrist about his experience with multiple sclerosis.

This podcast is sponsored by argenx. Visit www.vyvgarthcp.com for more information.

Disclosures can be found at Neurology.org.

Dr. Stacey Clardy talks with Dr. Carlayne E. Jackson about the state of neurology and the challenges and opportunities facing the field.

This podcast is sponsored by argenx. Visit www.vyvgarthcp.com for more information.

Disclosures can be found at Neurology.org.

Dr. Andy Southerland talks with Dr. Seemant Chaturvedi about recent trials presented at the European Stroke Organization Conference.

Show references:

Tenecteplase for Ischemic Stroke at 4.5 to 24 Hours without Thrombectomy

Rationale and Design of Tenecteplase Reperfusion Therapy in Acute Ischaemic Cerebrovascular Events III (TRACE III)

Colchicine for Prevention of Vascular Inflammation in Non-CardioEmbolic Stroke (CONVINCE)

Intensive Ambulance-Delivered Blood- Pressure Reduction in Hyperacute Stroke

This podcast is sponsored by argenx. Visit www.vyvgarthcp.com for more information.

Disclosures can be found at Neurology.org.